HEUKING advises MedTech start-up SkinLove on seed round
Bochum — SkinLove Ruhr GmbH, an innovative MedTech start-up from Bochum, has successfully completed a seed financing round.
The company was able to raise a mid-six-figure investment, which will be used to further develop and launch its revolutionary skin health solutions.
Founded in 2023 by Dr. Friederike Kogelheide, SkinLove Ruhr specializes in the development of cutting-edge cold plasma technology to effectively treat skin problems.
The company’s goal is to replace numerous consumable cosmetic products with its self-developed and German-made device.
This technology offers an innovative and sustainable alternative to conventional skincare products and aims to significantly improve users’ skin health.
SkinLove Ruhr successfully went through the accelerator program of Batch #1 of our partner HIGH-TECH.NRW and has recently launched its product successfully on the market.
The funds raised from the seed financing round will mainly be invested in the further development of the cold plasma technology and the preparation of the market launch.
In addition, SkinLove Ruhr plans to expand its production capacities and establish strategic partnerships in the health and cosmetics sector.
The seed financing round was legally advised by a team led by Dr. Patrick Müller, partner at the Düsseldorf office of the law firm HEUKING.
He was supported by Dr. Henrik Lay and Caroline Frohnwieser from Hamburg and Philipp Börger from Berlin.
HEUKING regularly advises young start-up entrepreneurs and supports them in all legal matters from their foundation to market entry. Advisors to SkinLove Ruhr GmbH: HEUKING Dr. Patrick Müller (lead), Düsseldorf, Dr. Henrik Lay, Caroline Frohnwieser, both Hamburg, Philipp Börger (all VC), Berlin